International Journal of Hematology

DOI: 10.1007/s12185-009-0295-4 Pages: 400-402

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

1. Wakayama Medical University, Department of Hematology/Oncology

2. Wakayama Medical University, 2nd Department of Pathology

3. Tenri Institute of Medical Research

4. Kansai University of Health Sciences, Division of Pathology and Immunology

Correspondence to:
Takashi Sonoki
Email: sonoki@wakayama-med.ac.jp

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

Share the Knowledge